Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Immunocore Holdings plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +3 vs. Q3 2021
- Shares held
- 17.7M
- +1.08M (+6.5%) vs. Q3 2021
- Total value
- $642.4M
- +$26.0M (+4.2%) vs. Q3 2021
- New holders
- 9
- 13 more added
- Sold out
- 6
- 14 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Hong Kong Ltd | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Kayne Anderson Rudnick Investment Management LLC | 3 | $0 | 0.00% | +3 | New |
| Tower Research Capital LLC (TRC) | 19 | $1.00K | 0.00% | +19 | New |
| State of Wyoming | 136 | $5.00K | 0.00% | −7−4.9% | Reduced |
| Advisor Group Holdings, Inc. | 144 | $5.00K | 0.00% | +21+17.1% | Added |
| Veritas Investment Partners (UK) Ltd. | 575 | $20.0K | 0.00% | +575 | New |
| Rockefeller Capital Management L.P. | 1,000 | $34.0K | 0.00% | +1,000 | New |
| Morgan Stanley | 1,405 | $48.0K | 0.00% | −916−39.5% | Reduced |
| Bank of America Corp | 3,558 | $121.0K | 0.00% | +1,305+57.9% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $132.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 5,523 | $189.0K | 0.07% | +164+3.1% | Added |
| Geode Capital Management, LLC | 5,997 | $205.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 6,316 | $216.0K | 0.00% | +116+1.9% | Added |
| Victory Capital Management Inc | 8,186 | $280.0K | 0.00% | −1,342−14.1% | Reduced |
| UBS Group AG | 9,445 | $323.0K | 0.00% | −4,556−32.5% | Reduced |
| Citadel Advisors LLC | 12,123 | $415.0K | 0.00% | −10,405−46.2% | Reduced |
| Point72 Asset Management, L.P. | 12,400 | $425.0K | 0.00% | −136,600−91.7% | Reduced |
| ETF Managers Group, LLC | 13,485 | $460.0K | 0.01% | −2,807−17.2% | Reduced |
| Pura Vida Investments, LLC | 19,071 | $653.0K | 0.07% | −30,929−61.9% | Reduced |
| Legal & General Group Plc | 22,369 | $765.0K | 0.00% | −2,908−11.5% | Reduced |
| Marshall Wace, LLP | 24,120 | $826.0K | 0.00% | +24,120 | New |
| TD Asset Management Inc | 27,506 | $942.0K | 0.00% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 30,676 | $1.05M | 0.03% | +30,676 | New |
| Alps Advisors Inc | 50,670 | $1.74M | 0.02% | −2,993−5.6% | Reduced |
| Omega Fund Management, LLC | 51,535 | $1.76M | 0.25% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 64,000 | $2.19M | 0.44% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 90,000 | $3.07M | 0.20% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 134,249 | $4.60M | 1.31% | +134,249 | New |
| Rathbone Brothers plc | 190,015 | $6.51M | 0.06% | +190,015 | New |
| Artal Group S.A. | 200,000 | $6.85M | 0.20% | 00.0% | Unchanged |
| Principal Financial Group Inc | 234,439 | $8.03M | 0.00% | +49,514+26.8% | Added |
| Pier Capital, LLC | 237,776 | $8.14M | 0.86% | +159,262+202.8% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 277,754 | $9.51M | 0.15% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 293,385 | $10.0M | 8.39% | +293,385 | New |
| Massachusetts Financial Services Co | 333,080 | $11.4M | 0.00% | −2,432−0.7% | Reduced |
| Thrivent Financial for Lutherans | 355,083 | $12.2M | 0.02% | +4,869+1.4% | Added |
| Perceptive Advisors LLC | 360,000 | $12.3M | 0.19% | −40,000−10.0% | Reduced |
| Price T Rowe Associates Inc | 379,891 | $13.0M | 0.00% | +17,865+4.9% | Added |
| BlackRock Inc. | 496,182 | $17.0M | 0.00% | −331,422−40.0% | Reduced |
| First Manhattan Co | 509,856 | $17.5M | 0.06% | +311,857+157.5% | Added |
| Bain Capital Public Equity Management II, LLC | 711,951 | $24.4M | 0.89% | +73,746+11.6% | Added |
| General Atlantic LLC | 950,000 | $32.5M | 0.25% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,230,000 | $42.1M | 0.89% | +134,400+12.3% | Added |
| RTW Investments, LP | 1,245,532 | $42.6M | 0.62% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,414,150 | $48.4M | 0.01% | +362,075+34.4% | Added |
| Bill & Melinda Gates Foundation | 576,923 | $55.8M | 16.93% | 00.0% | Unchanged |
| FMR LLC | 2,123,327 | $72.7M | 0.01% | −57,659−2.6% | Reduced |
| Rock Springs Capital Management LP | 2,471,555 | $84.6M | 1.96% | +26,400+1.1% | Added |
| Baker Bros. Advisors LP | 2,520,730 | $86.3M | 0.42% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −93,812−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −6,826−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −4,250−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −4,235−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |